294 related articles for article (PubMed ID: 31694340)
1. ADAM17 Activity and IL-6 Trans-Signaling in Inflammation and Cancer.
Schumacher N; Rose-John S
Cancers (Basel); 2019 Nov; 11(11):. PubMed ID: 31694340
[TBL] [Abstract][Full Text] [Related]
2. ADAM17 is required for EGF-R-induced intestinal tumors via IL-6 trans-signaling.
Schmidt S; Schumacher N; Schwarz J; Tangermann S; Kenner L; Schlederer M; Sibilia M; Linder M; Altendorf-Hofmann A; Knösel T; Gruber ES; Oberhuber G; Bolik J; Rehman A; Sinha A; Lokau J; Arnold P; Cabron AS; Zunke F; Becker-Pauly C; Preaudet A; Nguyen P; Huynh J; Afshar-Sterle S; Chand AL; Westermann J; Dempsey PJ; Garbers C; Schmidt-Arras D; Rosenstiel P; Putoczki T; Ernst M; Rose-John S
J Exp Med; 2018 Apr; 215(4):1205-1225. PubMed ID: 29472497
[TBL] [Abstract][Full Text] [Related]
3. ADAM17 orchestrates Interleukin-6, TNFα and EGF-R signaling in inflammation and cancer.
Schumacher N; Rose-John S
Biochim Biophys Acta Mol Cell Res; 2022 Jan; 1869(1):119141. PubMed ID: 34610348
[TBL] [Abstract][Full Text] [Related]
4. The role of ADAM17 during liver damage.
Al-Salihi M; Bornikoel A; Zhuang Y; Stachura P; Scheller J; Lang KS; Lang PA
Biol Chem; 2021 Aug; 402(9):1115-1128. PubMed ID: 34192832
[TBL] [Abstract][Full Text] [Related]
5. Epidermal growth factor receptor transactivation is implicated in IL-6-induced proliferation and ERK1/2 activation in non-transformed prostate epithelial cells.
Poncet N; Guillaume J; Mouchiroud G
Cell Signal; 2011 Mar; 23(3):572-8. PubMed ID: 21111811
[TBL] [Abstract][Full Text] [Related]
6. Short-term TNFα shedding is independent of cytoplasmic phosphorylation or furin cleavage of ADAM17.
Schwarz J; Broder C; Helmstetter A; Schmidt S; Yan I; Müller M; Schmidt-Arras D; Becker-Pauly C; Koch-Nolte F; Mittrücker HW; Rabe B; Rose-John S; Chalaris A
Biochim Biophys Acta; 2013 Dec; 1833(12):3355-3367. PubMed ID: 24135057
[TBL] [Abstract][Full Text] [Related]
7. Hormone-induced expression of tumor necrosis factor alpha-converting enzyme/A disintegrin and metalloprotease-17 impacts porcine cumulus cell oocyte complex expansion and meiotic maturation via ligand activation of the epidermal growth factor receptor.
Yamashita Y; Kawashima I; Yanai Y; Nishibori M; Richards JS; Shimada M
Endocrinology; 2007 Dec; 148(12):6164-75. PubMed ID: 17901238
[TBL] [Abstract][Full Text] [Related]
8. The metalloprotease ADAM17 in inflammation and cancer.
Düsterhöft S; Lokau J; Garbers C
Pathol Res Pract; 2019 Jun; 215(6):152410. PubMed ID: 30992230
[TBL] [Abstract][Full Text] [Related]
9. The shedding protease ADAM17: Physiology and pathophysiology.
Zunke F; Rose-John S
Biochim Biophys Acta Mol Cell Res; 2017 Nov; 1864(11 Pt B):2059-2070. PubMed ID: 28705384
[TBL] [Abstract][Full Text] [Related]
10. Functional Characterization of Colon Cancer-Associated Mutations in
Pavlenko E; Cabron AS; Arnold P; Dobert JP; Rose-John S; Zunke F
Int J Mol Sci; 2019 May; 20(9):. PubMed ID: 31060243
[TBL] [Abstract][Full Text] [Related]
11. ADAM17 controls IL-6 signaling by cleavage of the murine IL-6Rα from the cell surface of leukocytes during inflammatory responses.
Yan I; Schwarz J; Lücke K; Schumacher N; Schumacher V; Schmidt S; Rabe B; Saftig P; Donners M; Rose-John S; Mittrücker HW; Chalaris A
J Leukoc Biol; 2016 May; 99(5):749-60. PubMed ID: 26561568
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-11-driven gastric tumourigenesis is independent of trans-signalling.
Balic JJ; Garbers C; Rose-John S; Yu L; Jenkins BJ
Cytokine; 2017 Apr; 92():118-123. PubMed ID: 28160627
[TBL] [Abstract][Full Text] [Related]
13. Epithelial Cell-Derived a Disintegrin and Metalloproteinase-17 Confers Resistance to Colonic Inflammation Through EGFR Activation.
Shimoda M; Horiuchi K; Sasaki A; Tsukamoto T; Okabayashi K; Hasegawa H; Kitagawa Y; Okada Y
EBioMedicine; 2016 Mar; 5():114-24. PubMed ID: 27077118
[TBL] [Abstract][Full Text] [Related]
14. HB-EGF release mediates glucose-induced activation of the epidermal growth factor receptor in mesangial cells.
Uttarwar L; Peng F; Wu D; Kumar S; Gao B; Ingram AJ; Krepinsky JC
Am J Physiol Renal Physiol; 2011 Apr; 300(4):F921-31. PubMed ID: 21289053
[TBL] [Abstract][Full Text] [Related]
15. Enhancing Interleukin-6 and Interleukin-11 receptor cleavage.
Lokau J; Wandel M; Garbers C
Int J Biochem Cell Biol; 2017 Apr; 85():6-14. PubMed ID: 28143719
[TBL] [Abstract][Full Text] [Related]
16. Secreted Frizzled-related protein 3 (sFRP3)-mediated suppression of interleukin-6 receptor release by A disintegrin and metalloprotease 17 (ADAM17) is abrogated in the osteoarthritis-associated rare double variant of sFRP3.
Oldefest M; Düsterhöft S; Desel C; Thysen S; Fink C; Rabe B; Lories R; Grötzinger J; Lorenzen I
Biochem J; 2015 Jun; 468(3):507-18. PubMed ID: 25846075
[TBL] [Abstract][Full Text] [Related]
17. Insulin-induced ectodomain shedding of heparin-binding epidermal growth factor-like growth factor in adipocytes in vitro.
Yamamoto T; Suganami T; Kiso-Narita M; Scherle PA; Kamei Y; Isobe M; Higashiyama S; Ogawa Y
Obesity (Silver Spring); 2010 Oct; 18(10):1888-94. PubMed ID: 20111015
[TBL] [Abstract][Full Text] [Related]
18. ADAM17, shedding, TACE as therapeutic targets.
Rose-John S
Pharmacol Res; 2013 May; 71():19-22. PubMed ID: 23415892
[TBL] [Abstract][Full Text] [Related]
19. iRhoms 1 and 2 are essential upstream regulators of ADAM17-dependent EGFR signaling.
Li X; Maretzky T; Weskamp G; Monette S; Qing X; Issuree PD; Crawford HC; McIlwain DR; Mak TW; Salmon JE; Blobel CP
Proc Natl Acad Sci U S A; 2015 May; 112(19):6080-5. PubMed ID: 25918388
[TBL] [Abstract][Full Text] [Related]
20. ADAM17: An Emerging Therapeutic Target for Lung Cancer.
Saad MI; Rose-John S; Jenkins BJ
Cancers (Basel); 2019 Aug; 11(9):. PubMed ID: 31438559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
